These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18023395)

  • 1. Anti-TNFalpha therapy and vaccination of adults.
    Duchet-Niedziolka P; Coutsinos Z; Hanslik T; Launay O
    Joint Bone Spine; 2007 Dec; 74(6):563-5. PubMed ID: 18023395
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of influenza and pneumococci should be standard. Vaccination plan for rheumatic patients].
    MMW Fortschr Med; 2008 Oct; 150(44):12-3. PubMed ID: 19024485
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy.
    Fahy WA; Farnworth E; Yeldrem KP; Melling GS; Grennan DM
    Rheumatology (Oxford); 2006 Jul; 45(7):912-3. PubMed ID: 16638800
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Hua C; Barnetche T; Combe B; Morel J
    Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1016-26. PubMed ID: 24339395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset tuberculosis infection in patients receiving anti-TNFα therapy.
    Mongey AB; Doran JP; Kleinerova J; Fitzgerald O; McDonnell TJ
    QJM; 2014 Jan; 107(1):69-71. PubMed ID: 23970181
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumococcal vaccination for RA patients on TNF-alpha antagonists.
    Wright SA; Taggart AJ
    Rheumatology (Oxford); 2004 Apr; 43(4):523. PubMed ID: 15024137
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium chelonae infection associated with adalimumab therapy.
    Díaz F; Urkijo JC; Mendoza F; de la Viuda JM; Blanco M; Unzurrunzaga A; Ayarza R
    Scand J Rheumatol; 2008; 37(2):159-60. PubMed ID: 18415777
    [No Abstract]   [Full Text] [Related]  

  • 8. Infection and anti-tumor necrosis factor-alpha therapy.
    Zandman-Goddard G
    Isr Med Assoc J; 2003 Nov; 5(11):814-6. PubMed ID: 14650109
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.
    Hyrich KL; Silman AJ; Watson KD; Symmons DP
    Ann Rheum Dis; 2004 Dec; 63(12):1538-43. PubMed ID: 15242866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective prevention of secondary pneumococcal infection following influenza virus infection.
    Seon SH; Rhee DK
    Future Microbiol; 2018 Jul; 13():953-955. PubMed ID: 29947557
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
    Amano K
    Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccines in the assessment of patients for immune deficiency.
    Ballow M
    J Allergy Clin Immunol; 2012 Jul; 130(1):283-4.e5. PubMed ID: 22742841
    [No Abstract]   [Full Text] [Related]  

  • 13. The yin and yang of tumor necrosis factor inhibitors.
    Calabrese L
    Cleve Clin J Med; 2006 Mar; 73(3):251-6. PubMed ID: 16548447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients.
    Salliot C; Gossec L; Ruyssen-Witrand A; Luc M; Duclos M; Guignard S; Dougados M
    Rheumatology (Oxford); 2007 Feb; 46(2):327-34. PubMed ID: 16880188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the risk of infections in different anti-TNF agents: a meta-analysis.
    Liao H; Zhong Z; Liu Z; Zou X
    Int J Rheum Dis; 2017 Feb; 20(2):161-168. PubMed ID: 28160418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.
    Neven N; Vis M; Voskuyl AE; Wolbink GJ; Nurmohamed MT; Dijkmans BA; Lems WF
    Ann Rheum Dis; 2005 Apr; 64(4):645-6. PubMed ID: 15769924
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual pneumococcal and influenza vaccination in elderly patients with chronic illnesses: protective benefits overestimated?
    Ong R; Kwa AL; Lee W
    Clin Infect Dis; 2011 Feb; 52(4):558-9; author reply 559. PubMed ID: 21258113
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of active tuberculosis following initiation of infliximab despite appropriate prophylaxis.
    Raychaudhuri S; Shmerling R; Ermann J; Helfgott S
    Rheumatology (Oxford); 2007 May; 46(5):887-8. PubMed ID: 17363399
    [No Abstract]   [Full Text] [Related]  

  • 19. Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNFα therapy.
    Schoffelen T; Kampschreur LM; van Roeden SE; Wever PC; den Broeder AA; Nabuurs-Franssen MH; Sprong T; Joosten LA; van Riel PL; Oosterheert JJ; van Deuren M; Creemers MC
    Ann Rheum Dis; 2014 Jul; 73(7):1436-8. PubMed ID: 24794150
    [No Abstract]   [Full Text] [Related]  

  • 20. Infections and anti-tumor necrosis factor alpha therapy.
    Ellerin T; Rubin RH; Weinblatt ME
    Arthritis Rheum; 2003 Nov; 48(11):3013-22. PubMed ID: 14613261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.